Friedreich ataxia is an autosomal recessive neurological disorder caused by deficiency of the mitochondrial protein frataxin. Studies in patient cells, mouse knockout animals, and Saccharomyces cerevisiae models have suggested several hypotheses on the frataxin function, but the full physiology of frataxin in mitochondria has not been well established yet. We have characterized the genomic structure of frh-1, the Caenorhabditis elegans frataxin gene, and we have developed a transient knockdown model of C. elegans frataxin deficiency by RNA interference. frh-1(RNAi) worms show a consistent pleiotropic phenotype that includes slow growth, lethargic behavior, egg laying defects, reduced brood size, abnormal pharyngeal pumping, and altered defecation. Lifespan is significantly reduced, and worms have increased sensitivity to oxidative stress that, in turn, might explain the reduction of longevity of the worms. We also demonstrate synthetic genetic interaction between frh-1 and mev-1, the gene encoding the succinate dehydrogenase cytochrome b subunit of complex II in mitochondria, suggesting a possible role of the C. elegans frataxin in the electron transport chain; thus, the respiratory chain might be involved in the pathogenesis of the disease. We propose that this C. elegans model may be a useful biological tool for drug screening in Friedreich ataxia.
and nonsense mutations; however, these point mutations are always found in heterozygosis with an expanded GAA allele. GAA expansions reduce transcription of FRDA, which in turn leads to frataxin protein deficiency, the primary cause of the neurodegeneration observed in FRDA (2, 4, 5) . Patients carrying two null alleles have not been reported, and complete knockout of frataxin in mice causes embryonic lethality (6) , reflecting the importance of frataxin function for life in mammals.
Although a substantial effort has been made to elucidate the role of frataxin, its function is still not well understood. Most current data on the molecular mechanisms underlying the pathogenesis of frataxin deficiency have been obtained from the yeast model. Frataxin and Yfh1p, the S. cerevisiae frataxin ortholog, are located in the mitochondrial matrix tightly associated with the internal membrane (3, 7). Deletion of the yeast ortholog gene, yfh1Δ, results in mitochondrial iron accumulation (8) , high sensitivity to oxidative stress (8) (9) (10) , decreased activity of iron-sulfur cluster enzymes (11), defective energy metabolism, and defective oxidative phosphorylation (10) . Protein interaction experiments have identified interactions between yeast frataxin and several mitochondrial proteins. Yfh1p binds to Isu1p and Nfs1p, the proteins that make up the central iron sulfur cluster (ISC) assembling complex, indicating a function of frataxin in ISC biogenesis (12, 13) . Yeast Yfh1p also binds ferrochelatase, suggesting that frataxin may be involved in heme protein synthesis (14) . It has also been proposed that frataxin acts as an iron chaperone protein that modulates the activity of mitochondrial aconitase (15) , an iron-sulfur containing enzyme. Mitochondrial aconitase levels are decreased in patients (16) . As frataxin knockout in mouse is lethal, conditional knockout models have been developed. These involve cardiac and neuronal models. These models show biochemical and pathophysiological features of the human disease such as cardiodegeneration, large sensory neuron dysfunction, and abnormal activities of the respiratory chain I-III and aconitases. Interestingly, mice showed time-dependent iron accumulation in their hearts, which appeared only after decreased iron sulfur enzymatic activity, supporting the iron sulfur cluster assembling hypothesis (17) . Recently, these authors have also observed that mitochondrial iron accumulation does not induce oxidative stress and damage in murine tissues of conditional knockouts of frataxin (18) . This result is surprising as increased sensitivity to oxidative stress has been reported in both lower organisms, including yeast (8) (9) (10) , Candida albicans (19) , Arabidopsis thaliana (20) , and in FRDA patients (21, 22) . Thus the exact role of frataxin in FRDA remains unclear.
The nematode Caenorhabditis elegans is an animal model used for the study of several subjects, including cell biology, neurobiology, development, and cell death. The number of somatic cells in the hermaphrodite adult is 959 of which 302 are neurons. A complete lineage of every cell has been reported, and the complete neuronal wiring pattern is known. C. elegans is easy to maintain in the laboratory, has a short life cycle of 3 days at 20°C, and is fully transparent at all stages of life, allowing direct cell analysis. In addition its short generation time, small size, and the ability to grow in liquid culture make it feasible to rapidly screen thousands of chemicals for effects on the animal (23) . Genetic analysis and more recently knockdown by RNA interference (RNAi; refs 24, 25) are used extensively in C. elegans. RNAi results in varying levels of protein depletion. In many cases and circumstances depletion is partial, and this is particularly relevant to the study of the partial loss of frataxin function that is the real situation observed in human patients.
C. elegans has been used for the study of human diseases such as Duchenne muscular dystrophy (26), Alzheimer's disease (27) , spinal muscular atrophy (28), Huntington's disease (29) , and lissencephaly (30) . Homologues of many genes known to cause human disease are present in the worm (31) (32) (33) . Here we have characterized the C. elegans frataxin gene homologue, frh-1. We have also generated a model of frataxin deficiency by RNAi. The phenotype of the frh-1(RNAi) worms showed a wide and complex range of physiological alterations, including defects in pharynx pumping and defecation, abnormal response to oxidative stress, and shortened lifespan. We also show a synthetic interaction of frh-1 with mev-1, the gene encoding the succinate dehydrogenase cytochrome b subunit of the mitochondrial complex II, suggesting a possible role of frataxin in the respiratory chain.
MATERIAL AND METHODS

Strains and worm culture
Worms were cultured and maintained as described previously (34) . We used the following strains: wild type Bristol N2 and the mutant strain mev-1(kn1), which was supplied by the Caenorhabditis Genetics Centre (University of Minnesota, MN). All worms were cultured at 20°C (unless specified).
Characterization of the frh-1 RNA messenger and genomic locus
The frh-1 locus was detected using a BLAST (35) search using the protein sequence of the human frataxin. Two oligonucleotides were designed, based on the sequence of the predicted coding region, and used in RT-PCR to obtain the full-length cDNA: frh-1F 1 (5′-TGA TGT ATC TCA TGC AAT GGG), which hybridizes at the end of the first predicted exon and frh-1R 1 (5′-TTA GAC ATG TCG CGA GAA ATC), which does at the end of the third exon. We used frh-1F 1 for classic 3′ RACE (36) . frh-1R 1 was used in combination with SL-1 and SL-2 sequences (5′-GGT TTA ATT ACC CAA GTT TGA G and 5′-GGT TTT AAC CCA GTT ACT CAA G, respectively) to amplify the 5′end of the messenger. Both products were cloned into pGEM-T (Promega) and sequenced to confirm the structure of the gene.
RNAi
To produce the double-stranded RNA (dsRNA) of frh-1 we cloned the full-length cDNA of the gene into a pGEM-T vector (Promega). To obtain this fragment, we used the oligonucleotides frh-1F 5 (5′-ATG CTC TCC ACT ATT CTA CG) and frh-1R 1 . Then, we amplified the insert using primers to the T7 and SP6 promoter sequences. dsRNA was made using either T7 and SP6 RNA polymerases (Ambion) and combining the two single stranded molecules following a described previously method (37) . To obtain the F59G1.1 and ptp-2 dsRNA, we used as a template fragments of their correspondent cDNAs, using the primers F59G1.1F 1 (5′-GGA CTT TGT CTG TTC CAC GG) and F59G1.1R 1 (5′-AAG GAG CGG TGA GCT CAC GC) and ptp-2F 1 (5′-ATG CCA CGC CTA GCG CTG C) and ptp-2R 1 (5′-AAT TTG ATC TAC TAT CAT TCT GG), respectively. The dsRNA resuspended in water was injected into the distal part of the gonadal arms of young adult hermaphrodites. For the experiments related in results, we performed several injections, resulting always in a penetrance of >95% of the offspring.
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Phenotypic assays
Pharynx pumping
We counted contractions of the pharynx under the dissecting microscope, as described previously (38) . Ten L4 worms, for each treatment, were followed during five periods of 30 s. Experiments were performed with and without bacteria. The influence of serotonin in the worms was measured after incubation of the worms on NGM plus 7.5 mM serotonin plates, without bacteria. The Student's t test was used for statistical analysis.
Defecation
We followed a minimum of 10 worms under the dissecting microscope for either frh-1(RNAi), cat(RNAi) [E. coli chloramfenicol acetyl transferase], or N2 and counted a total number of 10 defecation cycles (from pBoc to next pBoc)] from each at 20 °C. The Student's t test was used for statistical analysis.
Lifespan assays
L4 larvae resulting from injected with dsRNA hermaphrodites were allowed to grow on NGM plates at 20 °C until they died. To avoid mixing test worms with their offspring, worms were transferred to a fresh plate everyday until they stopped laying eggs. The alive and dead worms were counted every other day at the beginning of the experiment and everyday after 8 days. Vitality was assessed by the animal response to gentle nose touch. Missing worms were scored as censored data. For statistical analysis, we compared survival curves using the Graphpad Prism software.
Oxidative stress experiments
A total number of 80 L4 larvae of the mev-1(kn1) strain, frh-1(RNAi), and cat(RNAi) were incubated in NGM plates, with 5 and 10 mM of paraquat (methyl viologen, Sigma) and no paraquat as a negative control. The experiments were carried out for 3 days at 25°C. We scored the number of alive and dead worms each day, following the same protocol as for lifespan assay. We compared survival curves using the Graphpad Prism software.
Synthetic genetic interaction test
The RNAi experiments were done by injection of dsRNA into 10 L4 hermaphrodites for both N2 and mev-1(kn1) strains. We injected dsRNA of frh-1 and cat into each strain. Injected worms were left on plates for 24 h. Then they were moved into fresh culture plates, and the initial plates were discarded, as the first eggs laid would not be affected by RNAi. The injected worms were allowed to lay eggs during a window of 18 h. Then, the mothers were removed and the eggs were allowed to develop for 24 more hours. We scored the number of unhatched dead eggs, and viable L1/L2 larvae. To obtain the proportion of dead eggs, we took the offspring of each injected animal as independent data. To examine sterility and/or arrested individuals, viable offspring were allowed to develop for 2 days. We used N2 and mev-1(kn1) worms not injected as negative controls. All experiments were carried out at 20°C.
Tracing spatial pattern of FRH-1 using GFP
GFP reporter constructs
To make frh-1::gfp1 we obtained a genomic DNA fragment of 8 kb by PCR with oligonucleotides frh-1F 2 and frh-1R 2 (5′-GTG ATG CGT GAT TCA CGA C and 5′-CTT ATT CAC TTC TGC TGG CC). This was cloned into pGEM-T (Promega). This insert contained the full-length frh-1 coding region together with 5 kb upstream and 2 kb downstream of the gene. Next, we inserted the gfp gene, from pPD113.05 (a gift of Andrew Fire, Carnegie Institution of Washington), in frame with the 134th codon, using a Bsp LU11 I site present in frh-1. frh-1::gfp2 was generated by amplifying a PCR fragment of the frh-1::gfp1 construct, with oligonucleotides frh-1F 3 and frh-1R 3 (5′-ATG CTC TCC ACT ATT CTA CG and 5′-CAG AGA TTT TTC CAC AGT TTC), and then we cloned it in pGEM-T. This fragment included 700 bp upstream of the start codon and the full-length of the frataxin gene, including its 3′ UTR. frh-1::gfp3 was generated by PCR fusion, using a genomic fragment of 10 kb upstream of frh-1 using the primers frh-1F 4 and frh-1R 4 (5′-TAC ACT TTC TCT TCG TAT TTC C and 5′-AGT CGA CCT GCA GGC ATG CAA GCT GTT TCG TAG AAT AGT GGA GAG). The reverse primer, frh-1R 4 , contains a short sequence at 5′, which overlaps with the beginning of the gfp gene, in pPD95.75 (a gift of Andrew Fire, Carnegie Institution of Washington). A gfp::unc-54-terminator fragment was amplified from pPD95.75 using oligonucleotides gfpF1 and gfpR1 (5′-AGC TTG CAT GCC TGC AGG TCG ACT and 5′-AAG GGC CCG TAC GGC CGA CTA GTA GG). Then, the gfp fragment was fused to the 8th codon of the frataxin gene of the genomic PCR product by nested PCR (39) . Chimeric constructs was visualized in a Leica TCS SP Confocal System.
Transgenic animals
N2 hermaphrodites were transformed by microinjection using a standard procedure (40) in a Leica DM IRB microscope. We injected 50-100 ng/μl of the test DNA together with the rol-6 (pRF4) reporter marker (41), up to 200 ng/μl final DNA concentration. In the case of the coinjection of the F59G1 cosmid and frh-1::gfp2, we mixed equal molar ratios of the DNAs, to a final concentration of 50 ng/μl of the DNA test. We obtained at least three independent strains carrying extrachromosomal arrays for each construct.
Mitochondrial localization
To determine the subcellular localization of the nematode FRH-1, frh-1::gfp transgenic worms were stained with the mitochondrial stain MitoTracker Deep Red 633 (Molecular Probes). Worms were treated with levamisol to reduce movements and then examined using a Leica TCS SP Confocal System.
RESULTS
Identification and characterization of frh-1, the C. elegans FRDA ortholog
Using the sequence of human frataxin as a probe in a BLAST analysis, we identified a single homologue in C. elegans, which we call frh-1 (frataxin homologue 1; GenBank accession no. AY048153). The predicted version of this gene was previously reported in the C. elegans genome database (Wormbase: http://www.wormbase.org/) as F59G1.7. To determine the mRNA structure, we amplified the frh-1 cDNA by RT-PCR. To determine the 5′ end of the cDNA, we took advantage of the trans-splicing phenomenon in C. elegans. Most genes in the worm use one of several RNA spliced leader sequences (SL), encoded elsewhere in the genome, which are trans-spliced onto the 5′ end of the message. There are two main types of spliced leader RNA called SL-1 and SL-2. It has been reported that monocistronic transcripts are trans-spliced with SL-1 and internal genes in polycistronic transcripts with SL-2, as eukaryotic operons (42) . Leading genes in C. elegans operons are trans-spliced by SL-1. We used oligonucleotides for SL-1 and SL-2 and an internal primer to amplify the 5′ end of the frataxin RNA messenger by RT-PCR. The 3′ end of the transcript was determined by 3′ RACE. In the 3′ end, we detected two polyadelynation sites (Fig. 1A) . The deduced gene structure confirms that predicted by the WormBase Consortium. The presence of both SL-1 and SL-2 spliced leaders on the frh-1 mRNA suggest that it may form part of an operon. Indeed frh-1 is part of the large predicted operon CEOP2232 (43) . Our analysis of this operon (Vázquez-Manrique et al., unpublished observations) suggests that it is a complex operon of 8 genes which contains a number of regulatory sequences and/or promoters. The presence of SL-1 and SL-2 imply that frh-1 is certainly a downstream gene in the operon but that it may also have its own promoter. The fulllength mRNA contains an ORF of 408 bp coding a protein of 136 amino acids. The predicted protein contains a 27 amino acid sequence in N terminus that is predicted by the program Mitoprot II (44) to target the protein to mitochondria.
Knockdown of frh-1 by RNAi causes a pleiotropic phenotype
Since our main aim is to establish a model in C. elegans for Friedreich ataxia, we wanted to emulate the partial loss of frataxin observed in patients. To achieve this we established partial knockdown of frh-1, using induction of RNAi by injection of dsRNA into the gonads of the worms. We found injection to be more effective than RNAi by feeding in this case (Vázquez-Manrique, unpublished observations). We generated dsRNA against an frh-1 mRNA fragment that includes the whole ORF and part of the 5′-UTR (Fig. 1B) . The F1 progeny of injected worms [(frh-1(RNAi)] showed several phenotypes ( Fig. 2) : slow growth (Gro), lethargic behavior, egg laying defects (Egl) representing difficulties to release eggs that accumulate in the uterus, reduced brood size, abnormal pharyngeal pumping (Eat), altered defecation (Dec), and larval lethality in a few individuals. These phenotypes are discussed in more detail below. In general, the worms appear small, thin, and pale and are not very active. Most of the affected animals took 20 h (or more) longer to reach adulthood than control worms. As a negative control, we used dsRNA for the cat gene [E. coli chloramphenicol acetyl transferase; cat(RNAi)].
As discussed above, the frh-1 gene is situated within an operon. This means that the gene could be transcribed as a polycistronic messenger. With the use of the ORF of the frh-1 gene as a target for RNAi, it is feasible that the polycistronic transcript could also be knocked down, thus resulting in the knockdown of one or more of the genes within the operon (45) . To ensure that this is not the case, we performed RNAi against the two flanking genes of frh-1 (F59G1.1 and ptp-2). We used part of their ORF as a template for the dsRNA (Fig. 1B) . No obvious phenotype was observed in either case, and therefore, we concluded that the observed phenotypes were specifically induced by knockdown of frh-1.
frh-1(RNAi) worms have abnormalities in pharyngeal pumping
Pharynx pumping in C. elegans is a physiological event that is also controlled by the nervous system (46) . In the absence of food, the pharynx pumps at a basal rate, but in the presence of food the pharynx responds by increasing the rate of pumping. In the presence of food, the pharyngeal pumping rate of the frh-1(RNAi) worms was significantly reduced when compared with control cat(RNAi) (Student's t test P<0.001; Fig. 3A) . The basal pumping rate appears to be largely unaltered. We also observed that pumping was arrhythmic. The coefficient of variation (CV) was significantly different between frh-1(RNAi) and cat(RNAi) worms (P<0.0001; Fig.  3B ). No significant differences were found between the CVs of frh-1(RNAi) and cat(RNAi) worms with no food (P<0.2), suggesting that the arrhythmia is generated when the pharynx is stimulated by the presence of food. To further delimit which tissue, muscle or neurons, is affected on the frh-1(RNAi) worms, we cultured them in the presence of serotonin. If the pharyngeal muscle function is intact serotonin is able to increase pumping of the animals in the absence of food. When 7.5 mM serotonin was added to worms in the absence of food, the pharynx pumping of the frh-1(RNAi) worms was increased to a higher rate than that measured in the frh-1(RNAi) worms in the presence of food, lower than the pumping rate of controls in the presence of food. This result suggests that the main problem in the frataxin-defective worms is due to a missfunction of the neurons that regulate pharyngeal pumping, although pharyngeal muscle function may also be compromised.
Frataxin deficiency affects normal defecation in C. elegans
Defecation in C. elegans is an ultradian rhythm. The defecation motor program (DMP) is initiated every 45 s and consists of three distinct steps: contraction of the posterior body wall muscle (pBoc), anterior body muscle contraction (aBoc), and expulsion of waste by contraction of the enteric muscle (Exp). This process is controlled by the nervous system and by cyclic Ca 2+ oscillations in the gut cells (47) . We compared defecation behavior in the frh-1(RNAi) animals with both wild-type N2 and control cat(RNAi) worms. We measured the interval time from pBoc to the next pBoc for 10 consecutive cycles per worm (n=10). We observed that frh-1(RNAi) individuals had a significantly increased mean period (mean cat(RNAi) =60 s and mean frh-1(RNAi) =92 s; Student's t test P < 0.03; Fig. 4A ). In addition, frh-1(RNAi) animals show a greater variability in the period of pBoc (Fig. 4B) . Both of these observations suggest a misregulation of the defecation oscillator.
frh-1(RNAi) worms show increased sensitivity to oxidative stress and have a reduced lifespan
To test whether the reduction of function of the frh-1 gene is also associated with increased sensitivity to oxidative stress, we performed experiments in which the RNAi worms were subjected to pro-oxidative stress environments. Some C. elegans mutants that have an increased sensitivity to oxidative stress are more susceptible to methyl viologen (paraquat) (48, 49) , so we tested the effect of paraquat on frh-1(RNAi) animals. As a positive control, we used the mev-1(kn1) strain, which shows high sensitivity to paraquat (48) . We incubated frh-1(RNAi), cat(RNAi), and mev-1(kn1) adult hermaphrodites in plates containing 0, 5, and 10 mM paraquat, respectively, at 25°C for three days, and assessed survival time. On the control plates, without paraquat, no deaths were observed during the course of the experiment. In contrast at 5 and 10 mM there was a significant increase (P<0.008 and P<0.0001, respectively) of deaths in frh-1(RNAi) worms compared with the cat(RNAi) controls (Fig. 5A) . mev-1 animals showed similar levels of sensitivity.
Increased oxidative stress has been observed in different mutant models of frataxin deficiency (8-10) and in cells from FRDA patients (50) . It is widely believed that lifespan and oxidative stress are intimately related. Thus increased oxidative stress may be related to the reduced life time of these organisms. This is the case in yeast frataxin mutants (yfh1∆). To asses how a decrease of frataxin affects the lifespan of C. elegans, we performed a lifespan assay. In addition to frh-1(RNAi) and cat(RNAi) animals, we also included the mev-1(kn1) homozygous mutant. mev-1(kn1) shows a higher sensitivity to oxidative stress and shortened lifespan (51, 52) . The mev-1 gene encodes MEV-1, the C. elegans ortholog of human succinate dehydrogenase subunit C (SDHC), which is one of the four subunits of the complex II of the mitochondrial electron transport chain. mev-1 mutants are hypersensitive to oxidative stress and age precociously due to increased superoxide anion production (53) . To perform the lifespan assay, we initially used 5-fluorodeoxyuridine (FUdR), which inhibits the production of offspring. FUdR is routinely used in such assays and has not previously been shown to interfere, substantially, with any other physiological events (54, 55) . The advantage of this method is that avoiding the production of offspring makes the experiment simpler, as there are no progeny to mix with the test individuals. Surprisingly, we saw an increase of the lifespan of the frh-1(RNAi) worms compared with cat(RNAi) and mev-1(kn1) animals in these experiments (data not shown). We next performed the experiment without FUdR. Under these conditions, the frh-1(RNAi) worms have a reduced lifespan. As these conditions are less artificial, we continued the experiments without FUdR. It is not clear why the use of FUdR affects in such a dramatic way the behavior of the frh-1(RNAi) worms. However, it may be worth further investigation of the aparent interaction between knocking down frataxin and the drug. In the absence of FUdR, the lifespan was reduced in both frh-1(RNAi) worms (half-life 10 days; n=153) and mev-1(kn1) mutants (half-life of 7.5 days; n=174). Differences were statistically significant (P<0.0001) when compared with the cat(RNAi) control worms (half-life 17 days; n=162; Fig. 5B ). It is likely that decreases of lifespan in the worms associated with reduced frataxin function may be related to increase of oxidative stress.
frh-1 and mev-1 interact functionally
The experiments described earlier revealed a similar result for frh-1(RNAi) worms and mev-1(kn1) mutants. Moreover, succinate dehydrogenase activity is decreased in yfh1∆ yeast strains, in mouse conditional knockouts, and in heart biopsies of patients. Interestingly, we have recently observed physical and genetic interactions between the Sdh1 and Sdh2 proteins, which are components of the S. cerevisiae mitochondrial complex II and Yfh1p in yeast (56) . We reasoned that the two proteins, FRH-1 and MEV-1, may be involved in the same biochemical pathway. To address this hypothesis, we designed genetic synthetic interaction experiments between frh-1 and mev-1. We performed RNAi against the frh-1 gene in both wild-type and mev-1 mutant backgrounds, and we assessed whether there was some enhancement of the phenotype of the mev-1(kn1) worms (previously, mev-1 worms had been outcrossed 5 times). The two genes show a highly synergistic phenotype. We observed 44% embryonic lethality in the frh-1(RNAi)/mev-1(kn1) double knockdown/mutant worms. This proportion was significantly different than wildtype, cat(RNAi), mev-1(kn1), and cat(RNAi)/mev-1(kn1) worms, all of which had very low
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levels of embryonic lethality (P<0.0001; Fig. 6 ). The embryos that hatched arrested at L1/L2 stages. Many of them showed some early gonad structures, but all of them were sterile. As a further control we also performed a similar synthetic interaction analysis injecting frh-1 dsRNA into the LB90 strain, carrying the mutant allele ctl-2(ua90) of the peroxisomal catalase gene. This strain shows shortened lifespan, as the mev-1(kn1) strain. We did not observe any significant difference in embryonic lethality between the frh-1(RNAi)/ctl-2(ua90) animals and ctl-2(ua90) worms injected with cat dsRNA (data not shown). These findings suggest that frh-1 and mev-1 interact genetically and indicate that frh-1 may have a role on the modulation of the complex II of the mitochondrial electron transport chain in C. elegans.
frh-1 has a complex expression pattern in adult C. elegans
RNAi of frh-1 results in a complex pleiotropic phenotype. To establish whether this complexity was reflected in the expression pattern of frataxin, we identified sites of frh-1 expression. To determine the expression pattern of frh-1, we generated three frh-1::gfp constructs, containing different flanking regions of the frh-1 gene and gfp fused to the frataxin coding sequence. In constructs frh-1::gfp1 and frh-1::gfp2, the gfp gene was inserted in frame after the 134th codon of the gene. frh-1::gfp1 also contained 5,359 bp and 2338 bp of the 5′ and 3′ genomic sequence upstream and downstream of frh-1, respectively, whereas frh-1::gfp2 contained the 670 bp genomic sequence upstream and 189 bp downstream of frh-1. In frh-1::gfp3, the gfp gene was fused to the 8th codon of frh-1 and also contained 12,234 bp upstream and 23 bp downstream the gene (Fig. 1B) . After introducing these constructs into N2 hermaphrodites by microinjection, we obtained several stable transgenic lines for each construct. Each construct showed slightly different gfp expression pattern, which suggests the presence of several promoter or regulatory sequences for frh-1 within the genomic region cloned. frh-1::gfp1 showed a complex expression pattern, which includes a number of neurons in the head. This construct also stains the muscle cells of the pharynx (Fig. 7A and B) , intestinal cells ( Fig. 7C and F) , body wall muscle cells (Fig.  7D) , and spermatheca. This construct was expressed in neurons that showed dendritic projections toward the mouth, suggesting that they may be sensory amphidic neurons (Fig. 7A, B, and C) . Costaining with DiI, which stains amphidic neurons in C. elegans, confirmed the amphidic nature of these cells (Fig. 7E) . frh-1::gfp2, which contains a smaller fragment (670 bp) upstream of frh-1 and the gene itself, was only expressed in these same neurons (data not shown). Interestingly, the frh-1::gfp3, which does not contain the frh-1 gene but contains all the 5′ sequence present in frh-1::gfp1, was not expressed in these neurons, suggesting the presence of a regulatory sequence within the frh-1 gene that would drive the expression of the gene in head neurons. On the other hand, the frh-1::gfp3 was expressed in the pharynx, gut cells, spermatheca, and body wall muscles (data not shown), as the frh-1::gfp1, indicating that frh-1::gfp1 would contain most of the necessary sequences for frataxin expression.
To further test the expression pattern, we performed an experiment aimed at testing a large region (>20 kb) upstream of frh-1, including the gene, fused to gfp. It has been shown that two different but homologous sequences of DNA may undergo recombination after being injected into the C. elegans gonads, thus forming arrays with a high frequency (57) . We therefore injected frh-1::gfp2 together with cosmid F59G1, which contains the whole sequence of the operon CEOP2232 excluding the final gene (F28B12.3). As expected, if homologous recombination had occurred, we obtained several stable lines that showed a complex expression pattern that resembled that observed with frh-1::gfp1 transgenic lines (Fig. 7G ) but was distinct from that Human and yeast frataxins are localized in the mitochondrial matrix (2, 3). To confirm the mitochondrial localization of FRH-1 in C. elegans, we performed staining experiments with MitoTracker in the frh-1::gfp1 transgenic worms. We observed colocalization of the frh-1 construct and the stain in the pharynx muscles (Fig. 8) .
DISCUSSION
Significant efforts have been made to understand function of frataxin in mitochondria and the molecular pathogenic mechanisms that underlay Friedreich ataxia. The high conservation of frataxin has enabled the development of a number of models, from the unicellular eukaryote S. cerevisiae to the mouse, which have in turn enabled significant advances in our understanding of frataxin function. In the present work, we have established a model in the nematode C. elegans that allows new approaches in the study of this protein and the disease. This organism is particularly useful for genetic and cell analyses. The availability of RNAi technology in C. elegans makes the generation of transient knockdown individuals straightforward, and this provides an easy and reproducible way of knocking down genes. C. elegans is also a good system for performing rapid screens for new drugs in the treatment of the disease. In contrast with knockouts, knocking down genes does not completely remove the function of a gene. Reducing the function of frataxin in C. elegans in by RNAi may be particularly relevant to study the pathophysiology of frataxin deficiency because patients' cells always have a residual quantity of frataxin.
An alternative approach to the disruption of frataxin function is through a gene knockout. During the course of this work a knockout strain VC389, carrying the allele frh-1(ok610), became available from The C. elegans Gene Knockout Consortium. We have outcrossed and balanced this strain (Vázquez-Manrique, unpublished observations). As mentioned, frh-1 is part of an operon with a complex regulatory pattern. This deletion removes part of the adjacent gene F59G1.1 (Fig. 1B) and has the potential to disrupt the function of other genes in the operon. We performed preliminary experiments to rescue the phenotype of this strain with frh-1 but have not so far been able to demonstrate that this phenotype is associated only with loss of frh-1. Because of these problems and more importantly because FRDA is associated with partial rather than full loss of frataxin, we have concentrated on the RNAi model.
In this work, we have obtained frh-1(RNAi) worms by microinjection of dsRNA against the full gene. The phenotype of F1 generation is highly reproducible. RNAi worms are thin, short, and more translucent, resembling a classic starved phenotype. They also show abnormalities in the growth rate, in the egg laying and brood size, and in the defecation cycle. They have disrupted pharyngeal pumping which may result in poor feeding which may, in turn, be the cause of the slow growth rate and of the reduced brood size. Disrupted pharyngeal pumping in the frh-1(RNAi) worms may be due to one or more causes. As we have demonstrated, these worms have an increased sensitivity to oxidative stress. This may be an indirect or direct consequence of the depletion of frataxin. It could be argued that increased oxidative stress may compromise the functioning of the pharyngeal muscle cells, and frataxin is expressed in these cells. Moreover mitochondrial dysfunction due to decreased frataxin function, as reported in cells from FRDA patients (58) , would cause a decrease in mitochondrial membrane potential and hence a reduction in energy available for proper pharyngeal pumping. On the other hand, the misfunction of pharynx pumping in the frh-1(RNAi) worms may be a consequence of a problem in the nervous system, a tissue highly enriched in frataxin (Fig. 7A, B, and E) . Pharynx pumping rate in C. elegans is dependent on the presence of the available resources. The nervous system, through the amphidic neurons, senses the food in the environment and sends the appropriate stimulus to the pharynx, increasing its rate of pharyngeal pumping (46) . If the neurons in charge of this process are compromised perhaps due to defects in oxidative stress management or mitochondrial function as described above, pharyngeal function may be affected.
Defecation is a physiological process that is dependent in intrinsic properties of the gut cells and proper neuronal function. The defecation cycle (DMP) can be reset by a sensory stimulus (46) . Then a misregulation of the sensory neurons could be a cause, at least in part, of the altered defecation of the frh-1(RNAi) worms. Frataxin is expressed in intestinal cells, and defects in the function of these cells may result from the defects in oxidative stress regulation or mitochondrial function discussed earlier. In addition, mitochondrial dysfunction could have a direct effect on Ca 2+ signaling, as mitochondria play important roles in controlling Ca 2+ signals (59, 60) . Consequently, any of these effects, or a combination of them, could account for the alterations of the defecation found in the frh-1(RNAi) worms.
Frequently, a reduction of function of important mitochondrial proteins is associated with an increase of lifespan in C. elegans, including some proteins associated to the mitochondrial transport chain (61). Thus we might expect that a reduction of frataxin in the worms would cause an increase in their lifespan. In contrast to this hypothesis, the yfh1Δ yeast mutants (62) and the frataxin conditional knockout mice (17) show premature ageing. In agreement with results from these model organisms, our model of frataxin deficient C. elegans shows a substantial reduction in its lifespan. However conditions do exist in which lifespan is increased, for example when we use the drug FUdR at 25°C. Recently, Ventura et al. (63) reported an increase in the lifespan of C. elegans where frataxin was depleted by RNAi by both injection and feeding. We have never observed increased lifespan in the absence of FUdR and at 20°C. Our results were obtained by microinjection of dsRNA of frh-1 directly into the gonads of L4 larvae, and analysis was performed in the offspring of those injected animals. In contrast, Ventura et al. performed microinjection in 5-day-old terminal size adults, and these animals were subjected to further study. Therefore, we think that there is no way to compare both kinds of experiments.
In our experiments, the lifespan of the frh-1(RNAi) was reduced, as in mev-1(kn1) worms. The mev-1 gene encodes succinate dehydrogenase cytochrome b subunit. mev-1 mutants are hypersensitive to oxidative stress and age precociously in part because of increased superoxide anion production (52, 64) . Such factors are widely believed to influence lifespan (51, 65) . Moreover, growing worms in antioxidant substances has the effect of lengthening lifespan (66, 67) . Longevity of C. elegans is also coupled to the rate of feeding, and Eat mutants that ingest bacteria less efficiently than wild-type worms live longer. frh-1(RNAi) animals probably have reduced food intake; nevertheless, they still show a significant decrease in their lifespan, suggesting that other factors are outweighing any gain in lifespan, due to the poor feeding. Based on hypersensitive response to the oxidative stress induced by paraquat of frh-1(RNAi) worms, we postulate that reduced lifespan may be the consequence, at least in part, of oxidative damage.
Work from other systems may help to answer the question of "how frataxin deficiency induces increased oxidative stress in mitochondria and, ultimately, in the nematode"? The possible connection of the frataxin to the mitochondrial electron transport chain has been suggested before. Frataxin defective yeast show defective energy metabolism and oxidative phosphorylation (12) . FRDA patients show, in vivo, a decrease in ATP production (68) , and interestingly, overexpression of frataxin in mammal cells gives rise to an increase in the rate of energy conversion (69) . In further support of this connection, using synthetic interaction experiments, we have demonstrated a genetic interaction between frh-1 and mev-1. This suggests that those gene products may be functioning in the same biochemical pathway, that is, the electron transport in the mitochondrial respiratory chain. Co-immunoprecipitation and synthetic lethal experiments in S. cerevisiae performed in one of our laboratories indicate that yeast yfh1p interacts with both the flavoprotein subunit sdh1p and the iron-sulfur subunit sdh2p of the succinate dehydrogenase complex (56) . Thus, we postulate that frataxin has a role in the modulation of the complex II and that absence or reduction of frataxin may induce overproduction of free radicals.
Here we show the characteristics of a model of frataxin deficiency in the nematode C. elegans. In combination with other experimental systems, this model will provide additional insights into the molecular mechanisms underlying frataxin deficiency and thus Friedreich ataxia and also will be a useful tool for drug screening. 
